Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort

Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review

(2014) April Armstrong et al.   CURRENT PHARMACEUTICAL DESIGN

Endothelial Dysfunction and the Effects of TNF Inhibitors on the Endothelium in Psoriasis and Psoriatic Arthritis: A Systematic Review

(2014) Elizabeth Brezinski et al.   CURRENT PHARMACEUTICAL DESIGN

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

(2013) Brendan M. Everett et al.   AMERICAN HEART JOURNAL

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

(2013) K.A. Papp et al.   BRITISH JOURNAL OF DERMATOLOGY

Psoriasis and New-Onset Diabetes: A Danish nationwide cohort study

(2013) U. Khalid et al.   DIABETES CARE

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study

(2013) O. Ahlehoff et al.   JOURNAL OF INTERNAL MEDICINE

Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis

(2013) Eleanor J. Samarasekera et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Major cardiovascular events associated with anti-IL 12/23 agents: A tale of two meta-analyses

(2013) Erica D. Dommasch et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies

(2013) Jeremy Hugh et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies

(2013) Ehrin J. Armstrong et al.   Journal of the American Heart Association

Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis

(2012) Jashin J. Wu et al.   ARCHIVES OF DERMATOLOGY

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials

(2012) T. Tzellos et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis and the Risk of Diabetes Mellitus

(2012) April W. Armstrong et al.   JAMA Dermatology

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

(2011) Paul M Ridker et al.   AMERICAN HEART JOURNAL

Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease

(2011) Renata Micha et al.   AMERICAN JOURNAL OF CARDIOLOGY

Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: A nationwide cohort study

(2011) Yi-Ju Chen et al.   ARTHRITIS AND RHEUMATISM

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study

(2011) K. Abuabara et al.   BRITISH JOURNAL OF DERMATOLOGY

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study

(2011) Ole Ahlehoff et al.   EUROPEAN HEART JOURNAL

The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity

(2011) Wolf-Henning Boehncke et al.   EXPERIMENTAL DERMATOLOGY

Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis

(2011) Daniel H. Solomon   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Psoriasis Carries an Increased Risk of Venous Thromboembolism: A Danish Nationwide Cohort Study

(2011) Ole Ahlehoff et al.   PLoS One

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

(2010) J. D. Greenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study

(2010) O. Ahlehoff et al.   JOURNAL OF INTERNAL MEDICINE

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

(2010) S. L. Westlake et al.   RHEUMATOLOGY

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis

(2009) A.B. Alexandroff et al.   BRITISH JOURNAL OF DERMATOLOGY

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

(2009) N. N. Mehta et al.   EUROPEAN HEART JOURNAL

The Risk of Stroke in Patients with Psoriasis

(2009) Joel M. Gelfand et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inflammation in Atherosclerosis

(2009) Peter Libby et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Vascular effects of biologic agents in RA and spondyloarthropathies

(2009) Zoltán Szekanecz et al.   Nature Reviews Rheumatology

AJC Editor's Consensus: Psoriasis and Coronary Artery Disease

(2008) Vincent E. Friedewald et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

(2008) Patrick W. Serruys et al.   CIRCULATION